IRIS Accounts Production v26.1.10.60 02110690 Board of Directors 1.1.25 31.12.25 31.12.25 Medium entities distributing medical support stockings and orthopaedic supports in the United Kingdom. true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 02110690 2024-12-31 02110690 2025-12-31 02110690 2025-01-01 2025-12-31 02110690 2023-12-31 02110690 2024-01-01 2024-12-31 02110690 2024-12-31 02110690 ns15:EnglandWales 2025-01-01 2025-12-31 02110690 ns14:PoundSterling 2025-01-01 2025-12-31 02110690 ns10:Director1 2025-01-01 2025-12-31 02110690 ns10:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 02110690 ns10:MediumEntities 2025-01-01 2025-12-31 02110690 ns10:Audited 2025-01-01 2025-12-31 02110690 ns10:Medium-sizedCompaniesRegimeForDirectorsReport 2025-01-01 2025-12-31 02110690 ns10:Medium-sizedCompaniesRegimeForAccounts 2025-01-01 2025-12-31 02110690 ns10:FullAccounts 2025-01-01 2025-12-31 02110690 ns10:OrdinaryShareClass1 2025-01-01 2025-12-31 02110690 ns10:Director2 2025-01-01 2025-12-31 02110690 ns10:RegisteredOffice 2025-01-01 2025-12-31 02110690 ns5:CurrentFinancialInstruments 2025-12-31 02110690 ns5:CurrentFinancialInstruments 2024-12-31 02110690 ns5:ShareCapital 2025-12-31 02110690 ns5:ShareCapital 2024-12-31 02110690 ns5:RetainedEarningsAccumulatedLosses 2025-12-31 02110690 ns5:RetainedEarningsAccumulatedLosses 2024-12-31 02110690 ns5:ShareCapital 2023-12-31 02110690 ns5:RetainedEarningsAccumulatedLosses 2023-12-31 02110690 ns5:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 02110690 ns5:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 02110690 ns5:PlantEquipmentOtherAssetsUnderOperatingLeases 2025-01-01 2025-12-31 02110690 ns5:PlantEquipmentOtherAssetsUnderOperatingLeases 2024-01-01 2024-12-31 02110690 ns5:OwnedAssets 2025-01-01 2025-12-31 02110690 ns5:OwnedAssets 2024-01-01 2024-12-31 02110690 1 2025-01-01 2025-12-31 02110690 1 2024-01-01 2024-12-31 02110690 ns5:FurnitureFittings 2024-12-31 02110690 ns5:MotorVehicles 2024-12-31 02110690 ns5:ComputerEquipment 2024-12-31 02110690 ns5:FurnitureFittings 2025-01-01 2025-12-31 02110690 ns5:MotorVehicles 2025-01-01 2025-12-31 02110690 ns5:ComputerEquipment 2025-01-01 2025-12-31 02110690 ns5:FurnitureFittings 2025-12-31 02110690 ns5:MotorVehicles 2025-12-31 02110690 ns5:ComputerEquipment 2025-12-31 02110690 ns5:FurnitureFittings 2024-12-31 02110690 ns5:MotorVehicles 2024-12-31 02110690 ns5:ComputerEquipment 2024-12-31 02110690 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-12-31 02110690 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-12-31 02110690 ns5:WithinOneYear 2025-12-31 02110690 ns5:WithinOneYear 2024-12-31 02110690 ns5:BetweenOneFiveYears 2025-12-31 02110690 ns5:BetweenOneFiveYears 2024-12-31 02110690 ns5:AllPeriods 2025-12-31 02110690 ns5:AllPeriods 2024-12-31 02110690 ns5:DeferredTaxation 2024-12-31 02110690 ns5:DeferredTaxation 2025-12-31 02110690 ns10:OrdinaryShareClass1 2025-12-31 02110690 ns5:RetainedEarningsAccumulatedLosses 2024-12-31

REGISTERED NUMBER: 02110690 (England and Wales)

| Strategic Report, |

| Report of the Directors and |

| Financial Statements |

| for the Year Ended 31 December 2025 |

| for |

| Medi UK Ltd |

Medi UK Ltd (Registered number: 02110690)

Contents of the Financial Statements

for the Year Ended 31 December 2025

Page |

Company Information | 1 |

Strategic Report | 2 |

Report of the Directors | 3 |

Report of the Independent Auditors | 4 |

Statement of Comprehensive Income | 8 |

Statement of Financial Position | 9 |

Statement of Changes in Equity | 10 |

Statement of Cash Flows | 11 |

Notes to the Statement of Cash Flows | 12 |

Notes to the Financial Statements | 13 |

Medi UK Ltd

Company Information

for the Year Ended 31 December 2025

| DIRECTORS: | A M L Holman

| G C Sciuchetti

| REGISTERED OFFICE: | Plough Lane

| Hereford

| Herefordshire

| HR4 0EL

| REGISTERED NUMBER: | 02110690 (England and Wales)

| AUDITORS: | Thorne Widgery Accountancy Ltd

| Chartered Accountants

| Statutory Auditors

| 2 Wyevale Business Park

| Kings Acre

| Hereford

| Herefordshire

| HR4 7BS

Medi UK Ltd (Registered number: 02110690)

Strategic Report

for the Year Ended 31 December 2025

The directors present their strategic report for the year ended 31 December 2025.

REVIEW OF BUSINESS

medi UK Ltd continues its principal activity to provide high quality medical devices to the Vascular and Orthopaedic markets within the UK healthcare sector. The majority of our business is with the NHS, both in acute and primary care. Growth has been achieved across most areas as we continue to help NHS Trusts to achieve the Government aim of bringing healthcare closer to home.

As the growth continues, we have invested in our Clinical team to support our customers.

We are committed to a sustainable future and to improving the environment, economy and wellbeing of the world in which we operate. In line with the National Health Service we are committed to becoming carbon neutral by 2045. The company fleet is now 70% electric and our packaging of products has been reduced in volume by 50% since 2019. Recycled materials now account of 85% of medi packing.

PRINCIPAL RISKS AND UNCERTAINTIES

Increasing costs of raw materials, fuel and labour have all had an impact on our business. medi UK are part of a global organisation and worldwide we have been able to mitigate the costs to some degree by forward purchasing raw materials and power supply.

Global supply chain disruptions have been identified as a risk and we continued to hold elevated stock levels to mitigate against any stock shortages.

Cyber security remains a focus for us with continued investments in training and support to help reduce the risks.

ON BEHALF OF THE BOARD:

A M L Holman - Director

17 April 2026

Medi UK Ltd (Registered number: 02110690)

Report of the Directors

for the Year Ended 31 December 2025

The directors present their report with the financial statements of the company for the year ended 31 December 2025.

DIVIDENDS

The total distribution of dividends for the year ended 31 December 2025 will be £ 850,000 .

DIRECTORS

The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

A M L Holman

G C Sciuchetti

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- | select suitable accounting policies and then apply them consistently;

- | make judgements and accounting estimates that are reasonable and prudent;

- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS

The auditors, Thorne Widgery Accountancy Ltd, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:

A M L Holman - Director

17 April 2026

Report of the Independent Auditors to the Members of

Medi UK Ltd

Opinion

We have audited the financial statements of Medi UK Ltd (the 'company') for the year ended 31 December 2025 which comprise the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows and Notes to the Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- | give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;

- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- | have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

- | the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- | the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of

Medi UK Ltd

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- | the financial statements are not in agreement with the accounting records and returns; or

- | certain disclosures of directors' remuneration specified by law are not made; or

- | we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of

Medi UK Ltd

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Based on our understanding of the Company, we identified that the principal risks of non-compliance with laws and regulations related to breaches of UK regulatory principles, such as those governed by the British Standards Institution, and we considered the extent to which non-compliance might have a material effect on the financial statements of the Company. We also considered those laws and regulations that have a direct impact on the financial statements of the Company such as the Companies Act 2006, the British Standards Institution and UK tax legislation.

We have also evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls) and determined that the principal risks are related to management bias in accounting estimates and judgemental areas of the financial statements.

Audit procedures performed by the engagement team included:

- Discussions with the Board, Management and Company Secretary involved in the Risk and Compliance functions and the Company's legal function, including consideration of known or suspected instances of non-compliance with laws and regulation and fraud;

- Evaluation and testing of the operating effectiveness of management's controls designed to prevent and detect irregularities;

- Assessment of matters reported on the Company's fraud register and the results of management's investigation of such matters;

- Identifying and testing journal entries based on risk criteria;

- Designing audit procedures to incorporate unpredictability around the nature, timing or extent of our testing; and

- Testing transactions entered into outside the normal course of the Company's business as appropriate.

There are inherent limitations in the audit procedures described above and, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusions.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of

Medi UK Ltd

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

KEVIN TONG ACA FCCA (Senior Statutory Auditor)

for and on behalf of Thorne Widgery Accountancy Ltd

Chartered Accountants

Statutory Auditors

2 Wyevale Business Park

Kings Acre

Hereford

Herefordshire

HR4 7BS

24 April 2026

Medi UK Ltd (Registered number: 02110690)

Statement of Comprehensive Income

for the Year Ended 31 December 2025

| 31.12.25 |  | 31.12.24

| Notes | £ | £ |

TURNOVER | 3 | 23,854,087 |  | 21,893,050 |  |

Cost of sales | (12,618,549 | ) | (11,376,991 | ) |

GROSS PROFIT | 11,235,538 |  | 10,516,059 |  |

Distribution costs | (3,235,486 | ) | (3,027,492 | ) |

Administrative expenses | (5,553,084 | ) | (5,234,412 | ) |

OPERATING PROFIT | 6 | 2,446,968 |  | 2,254,155 |  |

Interest receivable and similar income | 22,660 |  | 29,359 |  |

PROFIT BEFORE TAXATION | 2,469,628 |  | 2,283,514 |  |

Tax on profit | 7 | (630,144 | ) | (573,909 | ) |

PROFIT FOR THE FINANCIAL YEAR | 1,839,484 |  | 1,709,605 |  |

OTHER COMPREHENSIVE INCOME | - |  | - |  |

TOTAL COMPREHENSIVE INCOME FOR THE YEAR | 1,839,484 |  | 1,709,605 |  |

Medi UK Ltd (Registered number: 02110690)

Statement of Financial Position

31 December 2025

| 31.12.25 |  | 31.12.24

| Notes | £ | £ |

FIXED ASSETS

Tangible assets | 9 | 135,689 |  | 205,867 |  |

CURRENT ASSETS

Stocks | 10 | 2,491,402 |  | 2,130,757 |  |

Debtors | 11 | 4,056,355 |  | 3,534,394 |  |

Cash at bank and in hand | 1,417,964 |  | 1,517,386 |  |

7,965,721 |  | 7,182,537 |  |

CREDITORS

Amounts falling due within one year | 12 | (1,918,125 | ) | (2,190,959 | ) |

NET CURRENT ASSETS | 6,047,596 |  | 4,991,578 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 6,183,285 |  | 5,197,445 |  |

PROVISIONS FOR LIABILITIES | 14 | (28,930 | ) | (32,574 | ) |

NET ASSETS | 6,154,355 |  | 5,164,871 |  |

CAPITAL AND RESERVES

Called up share capital | 15 | 100,000 |  | 100,000 |  |

Retained earnings | 16 | 6,054,355 |  | 5,064,871 |  |

SHAREHOLDERS' FUNDS | 6,154,355 |  | 5,164,871 |  |

The financial statements were approved by the Board of Directors and authorised for issue on 17 April 2026 and were signed on its behalf by:

A M L Holman - Director

Medi UK Ltd (Registered number: 02110690)

Statement of Changes in Equity

for the Year Ended 31 December 2025

| Called up |

| share |  | Retained |  | Total

| capital |  | earnings |  | equity

£ | £ | £ |

Balance at 1 January 2024 | 100,000 |  | 4,855,266 |  | 4,955,266 |  |

Changes in equity

Dividends | - |  | (1,500,000 | ) | (1,500,000 | ) |

Total comprehensive income | - |  | 1,709,605 |  | 1,709,605 |  |

Balance at 31 December 2024 | 100,000 |  | 5,064,871 |  | 5,164,871 |  |

Changes in equity

Dividends | - |  | (850,000 | ) | (850,000 | ) |

Total comprehensive income | - |  | 1,839,484 |  | 1,839,484 |  |

Balance at 31 December 2025 | 100,000 |  | 6,054,355 |  | 6,154,355 |  |

Medi UK Ltd (Registered number: 02110690)

Statement of Cash Flows

for the Year Ended 31 December 2025

| 31.12.25 |  | 31.12.24

| Notes | £ | £ |

Cash flows from operating activities

Cash generated from operations | 1 | 1,288,845 |  | 2,708,640 |  |

Tax paid | (570,293 | ) | (526,323 | ) |

Net cash from operating activities | 718,552 |  | 2,182,317 |  |

Cash flows from investing activities

Purchase of tangible fixed assets | (6,484 | ) | (144,409 | ) |

Sale of tangible fixed assets | 15,850 |  | 3,299 |  |

Interest received | 22,660 |  | 29,359 |  |

Net cash from investing activities | 32,026 |  | (111,751 | ) |

Cash flows from financing activities

Equity dividends paid | (850,000 | ) | (1,500,000 | ) |

Net cash from financing activities | (850,000 | ) | (1,500,000 | ) |

(Decrease)/increase in cash and cash equivalents | (99,422 | ) | 570,566 |  |

Cash and cash equivalents at beginning of year | 2 | 1,517,386 |  | 946,820 |  |

Cash and cash equivalents at end of year | 2 | 1,417,964 |  | 1,517,386 |  |

Medi UK Ltd (Registered number: 02110690)

Notes to the Statement of Cash Flows

for the Year Ended 31 December 2025

1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

| 31.12.25 |  | 31.12.24

£ | £ |

| Profit before taxation | 2,469,628 |  | 2,283,514 |  |

| Depreciation charges | 64,422 |  | 24,740 |  |

| Profit on disposal of fixed assets | (3,750 | ) | (3,244 | ) |

| Finance income | (22,660 | ) | (29,359 | ) |

2,507,640 |  | 2,275,651 |  |

| (Increase)/decrease in stocks | (345,741 | ) | 134,687 |  |

| Increase in trade and other debtors | (518,869 | ) | (388,375 | ) |

| (Decrease)/increase in trade and other creditors | (354,185 | ) | 686,677 |  |

| Cash generated from operations | 1,288,845 |  | 2,708,640 |  |

2. | CASH AND CASH EQUIVALENTS

| The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts:

| Year ended 31 December 2025

| 31.12.25 |  | 1.1.25

£ | £ |

| Cash and cash equivalents | 1,417,964 |  | 1,517,386 |  |

| Year ended 31 December 2024

| 31.12.24 |  | 1.1.24

£ | £ |

| Cash and cash equivalents | 1,517,386 |  | 946,820 |  |

3. | ANALYSIS OF CHANGES IN NET FUNDS

| At 1.1.25 | Cash flow | At 31.12.25

£ | £ | £ |

| Net cash |

| Cash at bank and in hand | 1,517,386 |  | (99,422 | ) | 1,417,964 |  |

1,517,386 |  | (99,422 | ) | 1,417,964 |  |

| Total | 1,517,386 |  | (99,422 | ) | 1,417,964 |  |

Medi UK Ltd (Registered number: 02110690)

Notes to the Financial Statements

for the Year Ended 31 December 2025

1. | STATUTORY INFORMATION

| Medi UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Going Concern basis

| The directors have considered the basis on which the financial statements have been prepared and are confident that the going concern basis is appropriate for the following reasons:

| medi UK continued to adapt its approach to the ever-changing UK healthcare market. We have developed alternative routes to market and launched successful brand-new product concepts. Our focus remains on supporting UK clinicians in their demanding roles.

| Through prudent cost control and targeted sales activity, the company has exceeded the 2025 budget in sales and profit, adding to the capital of the company. The strong performance in business in 2025 shows the approach from medi UK has been well received.

| The company continued to trade profitably in the financial year.

| medi Holdings 2009 GmbH, the Parent company, has confirmed it will continue to provide support as and when required for a period of at least twelve months from the date the financial statements are signed off.

| A service contract extension of five years from August 2025 has been agreed with our UK service provider, Limbco. This allows for stability in all areas of our trading and encourages investment for both companies.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

| Equipment |  | - |  | Straight line over 5 years |  |

| Motor vehicles |  | - |  | Straight line to an estimated residual value over three years |  |

| Computer equipment |  | - |  | Straight line over 3 years |  |

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Medi UK Ltd (Registered number: 02110690)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | TURNOVER

| The turnover and profit before taxation are attributable to the one principal activity of the company.

4. | EMPLOYEES AND DIRECTORS

| 31.12.25 |  | 31.12.24

£ | £ |

| Wages and salaries | 2,937,931 |  | 2,817,361 |  |

| Social security costs | 409,579 |  | 374,837 |  |

| Other pension costs | 335,412 |  | 263,514 |  |

3,682,922 |  | 3,455,712 |  |

| The average number of employees during the year was as follows:

| 31.12.25 |  | 31.12.24

| Directors | 1 |  | 1 |  |

| Management and administrative staff | 6 |  | 14 |  |

| Sales staff | 35 |  | 30 |  |

42 |  | 45 |  |

Medi UK Ltd (Registered number: 02110690)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

5. | DIRECTORS' EMOLUMENTS

| 31.12.25 |  | 31.12.24

£ | £ |

| Directors' remuneration | 137,760 |  | 116,378 |  |

6. | OPERATING PROFIT

| The operating profit is stated after charging/(crediting):

| 31.12.25 |  | 31.12.24

£ | £ |

| Hire of plant and machinery | 1,248 |  | 1,617 |  |

| Depreciation - owned assets | 64,562 |  | 24,739 |  |

| Profit on disposal of fixed assets | (3,750 | ) | (3,244 | ) |

| Auditors remuneration | 16,555 |  | 14,396 |  |

7. | TAXATION

| Analysis of the tax charge

| The tax charge on the profit for the year was as follows:

| 31.12.25 |  | 31.12.24

£ | £ |

| Current tax:

| UK corporation tax | 633,788 |  | 540,294 |  |

| Deferred tax | (3,644 | ) | 33,615 |  |

| Tax on profit | 630,144 |  | 573,909 |  |

8. | DIVIDENDS

| During the year, total dividends of £850,000 (2024: £1,500,000) were paid to the parent company Medi Holdings 2009 GmbH.

Medi UK Ltd (Registered number: 02110690)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

9. | TANGIBLE FIXED ASSETS

| Motor |  | Computer |

| Equipment |  | vehicles |  | equipment |  | Totals

£ | £ | £ | £ |

| COST

| At 1 January 2025 | 47,526 |  | 212,030 |  | 25,393 |  | 284,949 |  |

| Additions | 3,644 |  | - |  | 2,840 |  | 6,484 |  |

| Disposals | - |  | (45,000 | ) | - |  | (45,000 | ) |

| At 31 December 2025 | 51,170 |  | 167,030 |  | 28,233 |  | 246,433 |  |

| DEPRECIATION

| At 1 January 2025 | 14,843 |  | 41,900 |  | 22,339 |  | 79,082 |  |

| Charge for year | 7,396 |  | 55,750 |  | 1,416 |  | 64,562 |  |

| Eliminated on disposal | - |  | (32,900 | ) | - |  | (32,900 | ) |

| At 31 December 2025 | 22,239 |  | 64,750 |  | 23,755 |  | 110,744 |  |

| NET BOOK VALUE

| At 31 December 2025 | 28,931 |  | 102,280 |  | 4,478 |  | 135,689 |  |

| At 31 December 2024 | 32,683 |  | 170,130 |  | 3,054 |  | 205,867 |  |

10. | STOCKS

| 31.12.25 |  | 31.12.24

£ | £ |

| Stocks | 2,491,402 |  | 2,130,757 |  |

11. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Trade debtors | 3,913,893 |  | 3,392,337 |  |

| Other debtors | 142,462 |  | 127,153 |  |

| Amounts owed by group undertakings | - |  | 14,904 |  |

4,056,355 |  | 3,534,394 |  |

| A deferred tax asset has arisen due to the taxable effect of timing differences of tangible fixed assets. These timing differences are expected to reduce in future periods.

12. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.12.25 |  | 31.12.24

£ | £ |

| Trade creditors | 396,825 |  | 327,674 |  |

| Amounts owed to group undertakings | 335,664 |  | 649,164 |  |

| Tax | 281,294 |  | 217,799 |  |

| Social security & other taxes | 80,007 |  | 85,203 |  |

| VAT | 578,757 |  | 395,477 |  |

| Other creditors | (1,200 | ) | 254 |  |

| Accruals and deferred income | 246,778 |  | 515,388 |  |

1,918,125 |  | 2,190,959 |  |

Medi UK Ltd (Registered number: 02110690)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

13. | LEASING AGREEMENTS

| Minimum lease payments under non-cancellable operating leases fall due as follows:

| 31.12.25 |  | 31.12.24

£ | £ |

| Within one year | 190,266 |  | 237,579 |  |

| Between one and five years | 85,858 |  | 168,670 |  |

276,124 |  | 406,249 |  |

14. | PROVISIONS FOR LIABILITIES

| 31.12.25 |  | 31.12.24

£ | £ |

| Deferred tax | 28,930 |  | 32,574 |  |

| Deferred |

| tax |

£ |

| Balance at 1 January 2025 | 32,574 |  |

| Movement in year | (3,644 | ) |

| Balance at 31 December 2025 | 28,930 |  |

15. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 31.12.25 |  | 31.12.24

| value: | £ | £ |

| 100,000 | Ordinary | £1 | 100,000 |  | 100,000 |  |

16. | RESERVES

| Retained

| earnings

£ |

| At 1 January 2025 | 5,064,871 |  |

| Profit for the year | 1,839,484 |  |

| Dividends | (850,000 | ) |

| At 31 December 2025 | 6,054,355 |  |

17. | PENSION COMMITMENTS

| The company encourages its employees to provide for their retirement. It matches contributions made by an employee to his or her personal pension scheme up to certain levels. Contributions payable under this policy are charged to the profit and loss account in the period to which they relate.

18. | ULTIMATE PARENT COMPANY

| Medi Holdings 2009 GmbH (incorporated in Germany ) is regarded by the directors as being the company's ultimate parent company.

Medi UK Ltd (Registered number: 02110690)

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

19. | RELATED PARTY DISCLOSURES

| Key management personnel are considered to be the directors. Details of remuneration are shown in note 5.